KORU Medical Systems, Inc. Income Charts

8 quarters of history · ending 2025-12-31 · SEC EDGAR

Source:10-K · 10-Q

Revenue, Gross Profit, Operating Income & Net Income

Margin (%)

Operating Expenses

Income Breakdown

Revenue↑+23.3% +$2M
$11M
Cost of Revenue↑+24.5% +$802K
$4M
Gross Profit↑+22.6% +$1M
$7M
R&D↑+2.7% +$31K
$1M
SG&A↑+3.7% +$214K
$6M
D&A↓-15.3% -$32K
$179K
Operating Income↑+49.1% +$836K
$-868K
EBITDA↓-15.3% -$32K
$179K
Interest Expense↓-17.1% -$14K
$67K
Other Income/Expense↓-30.3% -$71K
$164K
Pretax Income↑+50.8% +$803K
$-778K
Tax Provision↓-98.5% -$298K
$5K
Net Income↑+50.8% +$803K
$-778K
Gross Margin↓-0.4pts
62.6%
Operating Margin↑+12.5pts
-8.3%
Net Margin↑+11.8pts
-7.5%
Effective Tax Rate
0.0%
Deferred Tax Assets
Deferred Tax Liabilities
DTA Valuation Allowance↓-14.5% -$27K
$159K
ETR (Continuing Operations)
-0.8%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
-0.8%
Operating Lease Cost↓-0.8% -$1K
$146K
Revenue YoY Variation↑+0.3pts
23.3%
Income YoY Variation↑+44.2pts
49.1%
Revenue QoQ Variation↓-3.3pts
4.7%
Income QoQ Variation↓-134.6pts
-177.5%
No segment data available for this ticker. Source: quarterchart.com.